APO Research
Talk to an analyst

APO RESEARCH · REPORT

mRNA Raw Enzyme

mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.

Selected research

Market Structure

Global mRNA Raw Enzyme Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchmRNA Raw Enzyme Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA Raw Enzyme Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal mRNA Raw Enzyme Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA Raw Enzyme Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA Raw Enzyme Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.

The global mRNA Raw Enzyme market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for mRNA Raw Enzyme is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Europe market for mRNA Raw Enzyme is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for mRNA Raw Enzyme is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for mRNA Raw Enzyme is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of mRNA Raw Enzyme include Thermo Fisher, NEB, Merck, Aldevron, Roche CustomBiotech, Takara Bio Inc., Qiagen N.V., Promega and Novoprotein, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global mRNA Raw Enzyme market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of mRNA Raw Enzyme and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents mRNA Raw Enzyme revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the mRNA Raw Enzyme market size, projected growth trends, production technologies, key applications, and end-use industries.

mRNA Raw Enzyme Segment by Company

Thermo Fisher

NEB

Merck

Aldevron

Roche CustomBiotech

Takara Bio Inc.

Qiagen N.V.

Promega

Novoprotein

Alphazyme

LGC Biosearch Technologies

Jena Bioscience

Yeasen Biotechnology

Hongene Biotech

Enzo Biochem

Spindle (Applied DNA Sciences)

Vazyme

mRNA Raw Enzyme Segment by Type

Restriction Enzyme

RNA Polymerase

Capping Enzyme

Inorganic Pyrophosphatase

RNase Inhibitor

2'-O-Methyltransferase

Poly(A) Polymerase

DNase I

mRNA Raw Enzyme Segment by Application

Biopharmaceutical Companies

Academic and Research Institutes

mRNA Raw Enzyme Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Raw Enzyme market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA Raw Enzyme and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Raw Enzyme.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of mRNA Raw Enzyme in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global mRNA Raw Enzyme industry.

Chapter 3: Detailed analysis of mRNA Raw Enzyme companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Raw Enzymerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global mRNA Raw Enzyme Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Restriction Enzyme Table 3. Key Players of RNA Polymerase Table 4. Key Players of Capping Enzyme Table 3. Key Players of Inorganic Pyrophosphatase Table 4. Key Players of RNase Inhibitor Table 5. Key Players of 2'-O-Methyltransferase Table 6. Key Players of Poly(A) Polymerase Table 7. Key Players of DNase I Table 8. Global mRNA Raw Enzyme Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 9. Key Players of Biopharmaceutical Companies Table 10. Key Players of Academic and Research Institutes Table 11. Global mRNA Raw Enzyme Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global mRNA Raw Enzyme Market Size by Region (2021-2026) & (US$ Million) Table 13. Global mRNA Raw Enzyme Market Share by Region (2021-2026) Table 14. Global mRNA Raw Enzyme Market Size by Region (2027-2032) & (US$ Million) Table 15. Global mRNA Raw Enzyme Market Share by Region (2027-2032) Table 16. mRNA Raw Enzyme Industry Trends Table 17. mRNA Raw Enzyme Industry Drivers Table 18. mRNA Raw Enzyme Industry Opportunities and Challenges Table 19. mRNA Raw Enzyme Industry Restraints Table 20. Global mRNA Raw Enzyme Revenue by Company (US$ Million) & (2021-2026) Table 21. Global mRNA Raw Enzyme Revenue Market Share by Company (2021-2026) Table 22. Global mRNA Raw Enzyme Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global mRNA Raw Enzyme Key Company Head Office and Area Served Table 24. Global mRNA Raw Enzyme Company, Product Type & Application Table 25. Global mRNA Raw Enzyme Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global mRNA Raw Enzyme by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global mRNA Raw Enzyme Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global mRNA Raw Enzyme Market Size by Type (2021-2026) & (US$ Million) Table 30. Global mRNA Raw Enzyme Market Size by Type (2027-2032) & (US$ Million) Table 31. Global mRNA Raw Enzyme Revenue Market Share by Type (2021-2026) Table 32. Global mRNA Raw Enzyme Revenue Market Share by Type (2027-2032) Table 33. Global mRNA Raw Enzyme Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global mRNA Raw Enzyme Market Size by Application (2021-2026) & (US$ Million) Table 35. Global mRNA Raw Enzyme Market Size by Application (2027-2032) & (US$ Million) Table 36. Global mRNA Raw Enzyme Revenue Market Share by Application (2021-2026) Table 37. Global mRNA Raw Enzyme Revenue Market Share by Application (2027-2032) Table 38. Thermo Fisher Company Information Table 39. Thermo Fisher Business Overview Table 40. Thermo Fisher mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Thermo Fisher mRNA Raw Enzyme Product Portfolio Table 42. Thermo Fisher Recent Development Table 43. NEB Company Information Table 44. NEB Business Overview Table 45. NEB mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. NEB mRNA Raw Enzyme Product Portfolio Table 47. NEB Recent Development Table 48. Merck Company Information Table 49. Merck Business Overview Table 50. Merck mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Merck mRNA Raw Enzyme Product Portfolio Table 52. Merck Recent Development Table 53. Aldevron Company Information Table 54. Aldevron Business Overview Table 55. Aldevron mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Aldevron mRNA Raw Enzyme Product Portfolio Table 57. Aldevron Recent Development Table 58. Roche CustomBiotech Company Information Table 59. Roche CustomBiotech Business Overview Table 60. Roche CustomBiotech mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Roche CustomBiotech mRNA Raw Enzyme Product Portfolio Table 62. Roche CustomBiotech Recent Development Table 63. Takara Bio Inc. Company Information Table 64. Takara Bio Inc. Business Overview Table 65. Takara Bio Inc. mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Takara Bio Inc. mRNA Raw Enzyme Product Portfolio Table 67. Takara Bio Inc. Recent Development Table 68. Qiagen N.V. Company Information Table 69. Qiagen N.V. Business Overview Table 70. Qiagen N.V. mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Qiagen N.V. mRNA Raw Enzyme Product Portfolio Table 72. Qiagen N.V. Recent Development Table 73. Promega Company Information Table 74. Promega Business Overview Table 75. Promega mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Promega mRNA Raw Enzyme Product Portfolio Table 77. Promega Recent Development Table 78. Novoprotein Company Information Table 79. Novoprotein Business Overview Table 80. Novoprotein mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Novoprotein mRNA Raw Enzyme Product Portfolio Table 82. Novoprotein Recent Development Table 83. Alphazyme Company Information Table 84. Alphazyme Business Overview Table 85. Alphazyme mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Alphazyme mRNA Raw Enzyme Product Portfolio Table 87. Alphazyme Recent Development Table 88. LGC Biosearch Technologies Company Information Table 89. LGC Biosearch Technologies Business Overview Table 90. LGC Biosearch Technologies mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 91. LGC Biosearch Technologies mRNA Raw Enzyme Product Portfolio Table 92. LGC Biosearch Technologies Recent Development Table 93. Jena Bioscience Company Information Table 94. Jena Bioscience Business Overview Table 95. Jena Bioscience mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 96. Jena Bioscience mRNA Raw Enzyme Product Portfolio Table 97. Jena Bioscience Recent Development Table 98. Yeasen Biotechnology Company Information Table 99. Yeasen Biotechnology Business Overview Table 100. Yeasen Biotechnology mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 101. Yeasen Biotechnology mRNA Raw Enzyme Product Portfolio Table 102. Yeasen Biotechnology Recent Development Table 103. Hongene Biotech Company Information Table 104. Hongene Biotech Business Overview Table 105. Hongene Biotech mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 106. Hongene Biotech mRNA Raw Enzyme Product Portfolio Table 107. Hongene Biotech Recent Development Table 108. Enzo Biochem Company Information Table 109. Enzo Biochem Business Overview Table 110. Enzo Biochem mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 111. Enzo Biochem mRNA Raw Enzyme Product Portfolio Table 112. Enzo Biochem Recent Development Table 113. Spindle (Applied DNA Sciences) Company Information Table 114. Spindle (Applied DNA Sciences) Business Overview Table 115. Spindle (Applied DNA Sciences) mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 116. Spindle (Applied DNA Sciences) mRNA Raw Enzyme Product Portfolio Table 117. Spindle (Applied DNA Sciences) Recent Development Table 118. Vazyme Company Information Table 119. Vazyme Business Overview Table 120. Vazyme mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 121. Vazyme mRNA Raw Enzyme Product Portfolio Table 122. Vazyme Recent Development Table 123. North America mRNA Raw Enzyme Market Size by Type (2021-2026) & (US$ Million) Table 124. North America mRNA Raw Enzyme Market Size by Type (2027-2032) & (US$ Million) Table 125. North America mRNA Raw Enzyme Market Size by Application (2021-2026) & (US$ Million) Table 126. North America mRNA Raw Enzyme Market Size by Application (2027-2032) & (US$ Million) Table 127. North America mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. North America mRNA Raw Enzyme Market Size by Country (2021-2026) Table 129. North America mRNA Raw Enzyme Market Size by Country (2027-2032) Table 130. Europe mRNA Raw Enzyme Market Size by Type (2021-2026) & (US$ Million) Table 131. Europe mRNA Raw Enzyme Market Size by Type (2027-2032) & (US$ Million) Table 132. Europe mRNA Raw Enzyme Market Size by Application (2021-2026) & (US$ Million) Table 133. Europe mRNA Raw Enzyme Market Size by Application (2027-2032) & (US$ Million) Table 134. Europe mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe mRNA Raw Enzyme Market Size by Country (2021-2026) Table 136. Europe mRNA Raw Enzyme Market Size by Country (2027-2032) Table 137. China mRNA Raw Enzyme Market Size by Type (2021-2026) & (US$ Million) Table 138. China mRNA Raw Enzyme Market Size by Type (2027-2032) & (US$ Million) Table 139. China mRNA Raw Enzyme Market Size by Application (2021-2026) & (US$ Million) Table 140. China mRNA Raw Enzyme Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia mRNA Raw Enzyme Market Size by Type (2021-2026) & (US$ Million) Table 142. Asia mRNA Raw Enzyme Market Size by Type (2027-2032) & (US$ Million) Table 143. Asia mRNA Raw Enzyme Market Size by Application (2021-2026) & (US$ Million) Table 144. Asia mRNA Raw Enzyme Market Size by Application (2027-2032) & (US$ Million) Table 145. Asia mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia mRNA Raw Enzyme Market Size by Country (2021-2026) Table 147. Asia mRNA Raw Enzyme Market Size by Country (2027-2032) Table 148. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Type (2021-2026) & (US$ Million) Table 149. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Type (2027-2032) & (US$ Million) Table 150. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Application (2021-2026) & (US$ Million) Table 151. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Application (2027-2032) & (US$ Million) Table 152. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country (2021-2026) Table 154. South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country (2027-2032) Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. mRNA Raw Enzyme Product Image Figure 2. Global mRNA Raw Enzyme Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global mRNA Raw Enzyme Market Share by Type: 2025 VS 2032 Figure 4. Restriction Enzyme Image Figure 5. RNA Polymerase Image Figure 6. Capping Enzyme Image Figure 7. Inorganic Pyrophosphatase Image Figure 8. RNase Inhibitor Image Figure 9. 2'-O-Methyltransferase Image Figure 10. Poly(A) Polymerase Image Figure 11. DNase I Image Figure 12. Global mRNA Raw Enzyme Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global mRNA Raw Enzyme Market Share by Application: 2025 VS 2032 Figure 14. Biopharmaceutical Companies Image Figure 15. Academic and Research Institutes Image Figure 16. Global mRNA Raw Enzyme Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 18. Global mRNA Raw Enzyme Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global mRNA Raw Enzyme Market Share by Players in 2025 Figure 21. Global Top 5 and 10 mRNA Raw Enzyme Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global mRNA Raw Enzyme Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global mRNA Raw Enzyme Revenue Market Share by Type (2021-2032) Figure 25. Global mRNA Raw Enzyme Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global mRNA Raw Enzyme Revenue Market Share by Application (2021-2032) Figure 27. North America mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 28. North America mRNA Raw Enzyme Market Share by Type (2021-2032) Figure 29. North America mRNA Raw Enzyme Market Share by Application (2021-2032) Figure 30. North America mRNA Raw Enzyme Market Share by Country (2021-2032) Figure 31. United States mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 32. Canada mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 33. Mexico mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 34. Europe mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 35. Europe mRNA Raw Enzyme Market Share by Type (2021-2032) Figure 36. Europe mRNA Raw Enzyme Market Share by Application (2021-2032) Figure 37. Europe mRNA Raw Enzyme Market Share by Country (2021-2032) Figure 38. Germany mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 39. France mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 40. U.K. mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 41. Italy mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 42. Russia mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 44. China mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 45. China mRNA Raw Enzyme Market Share by Type (2021-2032) Figure 46. China mRNA Raw Enzyme Market Share by Application (2021-2032) Figure 47. Asia mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 48. Asia mRNA Raw Enzyme Market Share by Type (2021-2032) Figure 49. Asia mRNA Raw Enzyme Market Share by Application (2021-2032) Figure 50. Asia mRNA Raw Enzyme Market Share by Country (2021-2032) Figure 51. Japan mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 52. South Korea mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 55. India mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 56. Australia mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa mRNA Raw Enzyme Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa mRNA Raw Enzyme Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa mRNA Raw Enzyme Market Share by Country (2021-2032) Figure 61. Brazil mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 62. South Africa mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 64. Turkey mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 65. Argentina mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 66. UAE mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 67. Egypt mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 68. Chile mRNA Raw Enzyme Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Restriction Enzyme
  • RNA Polymerase
  • Capping Enzyme
  • Inorganic Pyrophosphatase
  • RNase Inhibitor
  • 2'-O-Methyltransferase
  • Poly(A) Polymerase
  • DNase I
Applications
  • Biopharmaceutical Companies
  • Academic and Research Institutes
Companies covered
  • Thermo Fisher
  • NEB
  • Merck
  • Aldevron
  • Roche CustomBiotech
  • Takara Bio Inc.
  • Qiagen N.V.
  • Promega
  • Novoprotein
  • Alphazyme
  • LGC Biosearch Technologies
  • Jena Bioscience
  • Yeasen Biotechnology
  • Hongene Biotech
  • Enzo Biochem
  • Spindle (Applied DNA Sciences)
  • Vazyme

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global mRNA Raw Enzyme Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Restriction Enzyme
  5. 1.2.3 RNA Polymerase
  6. 1.2.4 Capping Enzyme
  7. 1.2.5 Inorganic Pyrophosphatase
  8. 1.2.6 RNase Inhibitor
  9. 1.2.7 2'-O-Methyltransferase
  10. 1.2.8 Poly(A) Polymerase
  11. 1.2.9 DNase I
  12. 1.3 Market Analysis by Application
  13. 1.3.1 Global mRNA Raw Enzyme Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  14. 1.3.2 Biopharmaceutical Companies
  15. 1.3.3 Academic and Research Institutes
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global mRNA Raw Enzyme Growth Trends by Region
  18. 1.5.1 Global mRNA Raw Enzyme Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 mRNA Raw Enzyme Market Size by Region (2021-2026)
  20. 1.5.3 mRNA Raw Enzyme Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global mRNA Raw Enzyme Market Dynamics
  1. 2.1 mRNA Raw Enzyme Industry Trends
  2. 2.2 mRNA Raw Enzyme Industry Drivers
  3. 2.3 mRNA Raw Enzyme Industry Opportunities and Challenges
  4. 2.4 mRNA Raw Enzyme Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global mRNA Raw Enzyme Revenue by Company (2021-2026)
  2. 3.2 Global mRNA Raw Enzyme Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global mRNA Raw Enzyme Key Company Head office and Area Served
  4. 3.4 Global mRNA Raw Enzyme Company, Product Type & Application
  5. 3.5 Global mRNA Raw Enzyme Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global mRNA Raw Enzyme Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 mRNA Raw Enzyme Players Market Share by Revenue in 2025
  9. 3.6.3 2025 mRNA Raw Enzyme Tier 1, Tier 2, and Tier 3
4 mRNA Raw Enzyme Market by Type
  1. 4.1 Global mRNA Raw Enzyme Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global mRNA Raw Enzyme Market Size by Type (2021-2032)
  3. 4.3 Global mRNA Raw Enzyme Market Size Share by Type (2021-2032)
5 mRNA Raw Enzyme Market by Application
  1. 5.1 Global mRNA Raw Enzyme Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global mRNA Raw Enzyme Market Size by Application (2021-2032)
  3. 5.3 Global mRNA Raw Enzyme Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Thermo Fisher
  2. 6.1.1 Thermo Fisher Company Information
  3. 6.1.2 Thermo Fisher Business Overview
  4. 6.1.3 Thermo Fisher mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Thermo Fisher mRNA Raw Enzyme Product Portfolio
  6. 6.1.5 Thermo Fisher Recent Developments
  7. 6.2 NEB
  8. 6.2.1 NEB Company Information
  9. 6.2.2 NEB Business Overview
  10. 6.2.3 NEB mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 NEB mRNA Raw Enzyme Product Portfolio
  12. 6.2.5 NEB Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck mRNA Raw Enzyme Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Aldevron
  20. 6.4.1 Aldevron Company Information
  21. 6.4.2 Aldevron Business Overview
  22. 6.4.3 Aldevron mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Aldevron mRNA Raw Enzyme Product Portfolio
  24. 6.4.5 Aldevron Recent Developments
  25. 6.5 Roche CustomBiotech
  26. 6.5.1 Roche CustomBiotech Company Information
  27. 6.5.2 Roche CustomBiotech Business Overview
  28. 6.5.3 Roche CustomBiotech mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Roche CustomBiotech mRNA Raw Enzyme Product Portfolio
  30. 6.5.5 Roche CustomBiotech Recent Developments
  31. 6.6 Takara Bio Inc.
  32. 6.6.1 Takara Bio Inc. Company Information
  33. 6.6.2 Takara Bio Inc. Business Overview
  34. 6.6.3 Takara Bio Inc. mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Takara Bio Inc. mRNA Raw Enzyme Product Portfolio
  36. 6.6.5 Takara Bio Inc. Recent Developments
  37. 6.7 Qiagen N.V.
  38. 6.7.1 Qiagen N.V. Company Information
  39. 6.7.2 Qiagen N.V. Business Overview
  40. 6.7.3 Qiagen N.V. mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Qiagen N.V. mRNA Raw Enzyme Product Portfolio
  42. 6.7.5 Qiagen N.V. Recent Developments
  43. 6.8 Promega
  44. 6.8.1 Promega Company Information
  45. 6.8.2 Promega Business Overview
  46. 6.8.3 Promega mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Promega mRNA Raw Enzyme Product Portfolio
  48. 6.8.5 Promega Recent Developments
  49. 6.9 Novoprotein
  50. 6.9.1 Novoprotein Company Information
  51. 6.9.2 Novoprotein Business Overview
  52. 6.9.3 Novoprotein mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Novoprotein mRNA Raw Enzyme Product Portfolio
  54. 6.9.5 Novoprotein Recent Developments
  55. 6.10 Alphazyme
  56. 6.10.1 Alphazyme Company Information
  57. 6.10.2 Alphazyme Business Overview
  58. 6.10.3 Alphazyme mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Alphazyme mRNA Raw Enzyme Product Portfolio
  60. 6.10.5 Alphazyme Recent Developments
  61. 6.11 LGC Biosearch Technologies
  62. 6.11.1 LGC Biosearch Technologies Company Information
  63. 6.11.2 LGC Biosearch Technologies Business Overview
  64. 6.11.3 LGC Biosearch Technologies mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 LGC Biosearch Technologies mRNA Raw Enzyme Product Portfolio
  66. 6.11.5 LGC Biosearch Technologies Recent Developments
  67. 6.12 Jena Bioscience
  68. 6.12.1 Jena Bioscience Company Information
  69. 6.12.2 Jena Bioscience Business Overview
  70. 6.12.3 Jena Bioscience mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Jena Bioscience mRNA Raw Enzyme Product Portfolio
  72. 6.12.5 Jena Bioscience Recent Developments
  73. 6.13 Yeasen Biotechnology
  74. 6.13.1 Yeasen Biotechnology Company Information
  75. 6.13.2 Yeasen Biotechnology Business Overview
  76. 6.13.3 Yeasen Biotechnology mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Yeasen Biotechnology mRNA Raw Enzyme Product Portfolio
  78. 6.13.5 Yeasen Biotechnology Recent Developments
  79. 6.14 Hongene Biotech
  80. 6.14.1 Hongene Biotech Company Information
  81. 6.14.2 Hongene Biotech Business Overview
  82. 6.14.3 Hongene Biotech mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Hongene Biotech mRNA Raw Enzyme Product Portfolio
  84. 6.14.5 Hongene Biotech Recent Developments
  85. 6.15 Enzo Biochem
  86. 6.15.1 Enzo Biochem Company Information
  87. 6.15.2 Enzo Biochem Business Overview
  88. 6.15.3 Enzo Biochem mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Enzo Biochem mRNA Raw Enzyme Product Portfolio
  90. 6.15.5 Enzo Biochem Recent Developments
  91. 6.16 Spindle (Applied DNA Sciences)
  92. 6.16.1 Spindle (Applied DNA Sciences) Company Information
  93. 6.16.2 Spindle (Applied DNA Sciences) Business Overview
  94. 6.16.3 Spindle (Applied DNA Sciences) mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Spindle (Applied DNA Sciences) mRNA Raw Enzyme Product Portfolio
  96. 6.16.5 Spindle (Applied DNA Sciences) Recent Developments
  97. 6.17 Vazyme
  98. 6.17.1 Vazyme Company Information
  99. 6.17.2 Vazyme Business Overview
  100. 6.17.3 Vazyme mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Vazyme mRNA Raw Enzyme Product Portfolio
  102. 6.17.5 Vazyme Recent Developments
7 North America
  1. 7.1 North America mRNA Raw Enzyme Market Size (2021-2032)
  2. 7.2 North America mRNA Raw Enzyme Market Size by Type
  3. 7.2.1 North America mRNA Raw Enzyme Market Size by Type (2021-2026)
  4. 7.2.2 North America mRNA Raw Enzyme Market Size by Type (2027-2032)
  5. 7.2.3 North America mRNA Raw Enzyme Market Share by Type (2021-2032)
  6. 7.3 North America mRNA Raw Enzyme Market Size by Application
  7. 7.3.1 North America mRNA Raw Enzyme Market Size by Application (2021-2026)
  8. 7.3.2 North America mRNA Raw Enzyme Market Size by Application (2027-2032)
  9. 7.3.3 North America mRNA Raw Enzyme Market Share by Application (2021-2032)
  10. 7.4 North America mRNA Raw Enzyme Market Size by Country
  11. 7.4.1 North America mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America mRNA Raw Enzyme Market Size by Country (2021-2026)
  13. 7.4.3 North America mRNA Raw Enzyme Market Size by Country (2027-2032)
  14. 7.4.4 North America mRNA Raw Enzyme Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe mRNA Raw Enzyme Market Size (2021-2032)
  2. 8.2 Europe mRNA Raw Enzyme Market Size by Type
  3. 8.2.1 Europe mRNA Raw Enzyme Market Size by Type (2021-2026)
  4. 8.2.2 Europe mRNA Raw Enzyme Market Size by Type (2027-2032)
  5. 8.2.3 Europe mRNA Raw Enzyme Market Share by Type (2021-2032)
  6. 8.3 Europe mRNA Raw Enzyme Market Size by Application
  7. 8.3.1 Europe mRNA Raw Enzyme Market Size by Application (2021-2026)
  8. 8.3.2 Europe mRNA Raw Enzyme Market Size by Application (2027-2032)
  9. 8.3.3 Europe mRNA Raw Enzyme Market Share by Application (2021-2032)
  10. 8.4 Europe mRNA Raw Enzyme Market Size by Country
  11. 8.4.1 Europe mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe mRNA Raw Enzyme Market Size by Country (2021-2026)
  13. 8.4.3 Europe mRNA Raw Enzyme Market Size by Country (2027-2032)
  14. 8.4.4 Europe mRNA Raw Enzyme Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China mRNA Raw Enzyme Market Size (2021-2032)
  2. 9.2 China mRNA Raw Enzyme Market Size by Type
  3. 9.2.1 China mRNA Raw Enzyme Market Size by Type (2021-2026)
  4. 9.2.2 China mRNA Raw Enzyme Market Size by Type (2027-2032)
  5. 9.2.3 China mRNA Raw Enzyme Market Share by Type (2021-2032)
  6. 9.3 China mRNA Raw Enzyme Market Size by Application
  7. 9.3.1 China mRNA Raw Enzyme Market Size by Application (2021-2026)
  8. 9.3.2 China mRNA Raw Enzyme Market Size by Application (2027-2032)
  9. 9.3.3 China mRNA Raw Enzyme Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia mRNA Raw Enzyme Market Size (2021-2032)
  2. 10.2 Asia mRNA Raw Enzyme Market Size by Type
  3. 10.2.1 Asia mRNA Raw Enzyme Market Size by Type (2021-2026)
  4. 10.2.2 Asia mRNA Raw Enzyme Market Size by Type (2027-2032)
  5. 10.2.3 Asia mRNA Raw Enzyme Market Share by Type (2021-2032)
  6. 10.3 Asia mRNA Raw Enzyme Market Size by Application
  7. 10.3.1 Asia mRNA Raw Enzyme Market Size by Application (2021-2026)
  8. 10.3.2 Asia mRNA Raw Enzyme Market Size by Application (2027-2032)
  9. 10.3.3 Asia mRNA Raw Enzyme Market Share by Application (2021-2032)
  10. 10.4 Asia mRNA Raw Enzyme Market Size by Country
  11. 10.4.1 Asia mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia mRNA Raw Enzyme Market Size by Country (2021-2026)
  13. 10.4.3 Asia mRNA Raw Enzyme Market Size by Country (2027-2032)
  14. 10.4.4 Asia mRNA Raw Enzyme Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa mRNA Raw Enzyme Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Type
  3. 11.2.1 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa mRNA Raw Enzyme Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Application
  7. 11.3.1 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa mRNA Raw Enzyme Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country
  11. 11.4.1 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa mRNA Raw Enzyme Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa mRNA Raw Enzyme Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst